Exploratory analyses showed that low VEGF-A levels were associated with longer progression-free survival ( @ versus @ months ; hazard ratio , @ ; @ % confidence intervals , @ to @ ; p = @ ) and overall survival ( @ versus @ months ; hazard ratio , @ ; @ % confidence interval , @-@ @ ; p = @ ) compared with these in high baseline plasma VEGF-A levels .